Evidence map›Paper›PMID 28287425›Full record

ArticleJournal of clinical medicine2017

The Relationship between Mitochondrial Respiratory Chain Activities in Muscle and Metabolites in Plasma and Urine: A Retrospective Study.

Corinne Alban, Elena Fatale, Abed Joulani, Polina Ilin, Ann Saada

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Biomarkers of mitochondrial disorders.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  5. Article
  6. The Biochemical Assessment of Mitochondrial Respiratory Chain Disorders.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Corinne AlbanMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, P.O. Box 12000, 91120 Jerusalem, Israel. korin@hadassah.org.il.
Elena FataleMetabolic Laboratory, Department of Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, P.O. Box 12000, 91120 Jerusalem, Israel. fatalelena@yahoo.com.
Abed JoulaniMetabolic Laboratory, Department of Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, P.O. Box 12000, 91120 Jerusalem, Israel. abedg@hadassah.org.il.
Polina IlinMetabolic Laboratory, Department of Genetics and Metabolic Diseases, Hadassah-Hebrew University Medical Center, P.O. Box 12000, 91120 Jerusalem, Israel. ilin@hadassah.org.il.
Ann SaadaMonique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, P.O. Box 12000, 91120 Jerusalem, Israel. annsr@hadassah.org.il.
Hadassah Medical Center · ILHebrew University of Jerusalem · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between 114 cases with decreased enzymatic activities of mitochondrial respiratory chain (MRC) complexes I-V (C I-V) in muscle and metabolites in urine and plasma was retrospectively examined. Less than 35% disclosed abnormal plasma amino acids and acylcarnitines, with elevated alanine and low free carnitine or elevated C4-OH-carnitine as the most common findings, respectively. Abnormal urine organic acids (OA) were detected in 82% of all cases. In CI and CII defects, lactic acid (LA) in combination with other metabolites was the most common finding. 3-Methylglutaconic (3MGA) acid was more frequent in CIV and CV, while Tyrosine metabolites, mainly 4-hydroxyphenyllactate, were common in CI and IV defects. Ketones were present in all groups but more prominent in combined deficiencies. There was a significant strong correlation between elevated urinary LA and plasma lactate but none between urine Tyrosine metabolites and plasma Tyrosine or urinary LA and plasma Alanine. All except one of 14 cases showed elevated FGF21, but correlation with urine OA was weak. Although this study is limited, we conclude that urine organic acid test in combination with plasma FGF21 determination are valuable tools in the diagnosis of mitochondrial diseases.

Indexed as

FGF21mitochondrial diseasemitochondrial respiratory chainplasma amino acidsplasma carnitinesurine organic acid

Identifiers

PMID28287425
PMCPMC5373000
OpenAlexW2592922914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.